Results 101 to 110 of about 14,856,300 (187)

Peripheral T-Cell Lymphoma: What's Next? [PDF]

Hematol Oncol
Yoon SE, Kim WS.
europepmc   +1 more source

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study. [PDF]

Br J Haematol
Abeyakoon C, Wellard C, Murad V, Chung E, Hodgson D, Rodin D, Prica A, Aoki T, Vijenthira A, Falcone U, Opat S, Wood EM, McQuilten ZK, Hawkes EA, Crump M, Kuruvilla J, Gregory GP.   +16 more
europepmc   +1 more source

Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study. [PDF]

Blood Adv
Ruan J, Chen Z, Larson MC, Bennani NN, Allen P, Mou E, Wallace D, Mehta-Shah N, Lossos IS, Malpica Castillo LE, Jaye DL, Vega F, Inghirami G, Pongas G, Akkad N, Casulo C, Martin P, Cohen JB, Habermann TM, Maurer MJ, Leonard JP, Friedberg JW, Kahl B, Cerhan JR, Flowers CR, Feldman AL.   +25 more
europepmc   +1 more source

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis. [PDF]

Blood Cancer J
Wang J, Gao Y, Bennani NN, Tiger YK, Khurana A, Durani U, Paludo J, Thanarajasingam G, Hwang SR, Wang Y, Nowakowski GS, Habermann TM, Witzig TE, Ansell SM, Abeykoon JP.   +14 more
europepmc   +1 more source

Care Patterns, Outcomes, and Costs in Peripheral T-Cell Lymphoma Patients with First-Line Treatment in Routine Clinical Practice in Europe. [PDF]

J Blood Med
Kristo F, Kelkar SS, Raina R, Schmier JK, Dalal MR, Ashaye AO.   +5 more
europepmc   +1 more source

Beyond the Rash: Cutaneous Peripheral T-Cell Lymphoma as a Diagnostic Pitfall in Primary Care. [PDF]

Cureus
Hensley J, Calderon A, Martin BC, Kochi C, Suarez Parraga AR.   +4 more
europepmc   +1 more source

Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Observational Study. [PDF]

Am J Hematol
Donglu Z, Yuqin S, Jiayue Q, Hongyan T, Kaiyang D, Qingqing C, Huiqiang H, Lili W, Hongmei J, Liling Z, Wenbin Q, Ou B, Shanbo C, Jie J, Jun Z, Jun M.   +15 more
europepmc   +1 more source

Safety and Effectiveness of Denileukin Diftitox-cxdl in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma: An All-Case Post-Marketing Study in Japan. [PDF]

Cancer Rep (Hoboken)
Jo T, Matsumoto K, Ishii M, Izutsu K.
europepmc   +1 more source

Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype. [PDF]

J Cutan Pathol
Planella-Fontanillas N, Molina-Alvarez A, Colomo-Saperas L, Rovira R, Gonzàlez-Farré M, Barranco-Sanz C, Calvo X, Nadal-Pellisé C, Gallardo F, Pujol RM.   +9 more
europepmc   +1 more source

LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling. [PDF]

Oncogene
Wang C, Cai MC, Cheng S, Hu S, Huang YH, Zhao LJ, Qin Y, Qiu YR, Dou HJ, Tan YH, Gao SJ, Xiong J, Zhao WL.   +12 more
europepmc   +1 more source